Anti-Human IgG (Fc specific)−Alkaline Phosphatase antibody produced in goat

affinity isolated antibody, buffered aqueous solution

anti human IgG antibody, Anti Human Igg, Anti-Human Igg, Anti-Human IgG Antibody - Anti-Human IgG (Fc specific)-Alkaline Phosphatase antibody produced in goat
MDL number:

Quality Level

biological source


antibody form

affinity isolated antibody

antibody product type

secondary antibodies




buffered aqueous solution


direct ELISA: 1:55,000
dot blot: 1:40,000 (chemiluminescent)
immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:150


alkaline phosphatase conjugate

shipped in

wet ice

storage temp.


Related Categories

General description

Human IgGs are glycoprotein antibodies that contain two equivalent light chains and a pair of identical heavy chains. IgGs have four distinct isoforms, ranging from IgG1 to IgG4. Immunoglobulin G (IgG) belongs to the immunoglobulin family and is a widely expressed serum antibody. IgG is usually found as a monomer. IgG antibody subtype is the most abundant of serum immunoglobulins of the immune system. About 70 percent of the total immunoglobulin consists of IgG. Immunoglobulin G (IgG) participates in hypersensitivity type II and type III. Anti-Human IgG (Fc specific)-Alkaline Phosphatase antibody is specific for human IgG and human IgG, Fc fragment. The product does not react with human IgG, Fab fragment, light chains, IgA, and IgM. Additionally, the antibody does not bind to mouse and rat IgG. Goat anti-human IgG is conjugated to alkaline phosphatase by protein cross linking with 0.2% glutaraldehyde.


Specificity of the Anti-Human IgG is determined prior to conjugation by ELISA. The conjugate is specific for human IgG and human IgG, Fc fragment. Cross reactivity of the antibody-conjugate is also determined by ELISA. The conjugate shows no reactivity with human IgG, Fab fragment, human light chains, human IgA, human IgM or with mouse IgG and rat IgG.
Binds human IgG; does not bind other human Igs.
Provides reduced background with mouse or rat samples.


Human IgG, Fc fragment


Anti-Human IgG (Fc specific)-Alkaline Phosphatase antibody is suitable for use in ELISA and western blot at 1:5000 dilutions. The product can also be used for dot blot (1:40,000) and immunohistochemistry (1:150 using formalin-fixed, paraffin-embedded sections).

Anti-Human IgG (Fc specific)-Alkaline Phosphatase antibody has been used in
  • quantitative sandwich ELISA
  • α-GalC ELISA
  • ELISA assays
  • ELISAs for IgG subclasses
A modified monoclonal antibody specific immobilization of platelet antigens (MAIPA) assay was performed on human platelet eluates using alkaline phosphatase-conjugated goat anti-human, Fc specific, antibody as the secondary with a 30 minute incubation.

Biochem/physiol Actions

Immunoglobulin G (IgG) regulates immunological responses to allergy and pathogenic infections. IgGs have also been implicated in complement fixation and autoimmune disorders. Immunoglobulin G (IgG) mainly participates in hypersensitivity type II and type III.

Physical form

Solution in 0.05 M Tris, pH 8.0, containing 1% BSA, 1 mM MgCl2 and 15 mM sodium azide

Storage and Stability

Store at 2-8 °C. Do Not Freeze.

Other Notes

No cross-reaction with mouse and rat IgG.
Working dilutions should be determined by titration assay. Due to differences in assay systems, these titers may not reflect the user′s actual working dilution.


Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.


NONH for all modes of transport

WGK Germany


Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificate of Analysis
Certificate of Origin
Calabi F and Neuberger M S
Molecular Genetics of Immunoglobulin, 17 (1987)
Sreenivasulu B Reddy et al.
PloS one, 7(2), e32242-e32242 (2012-03-01)
Malaria kills almost 1 million people every year, but the mechanisms behind protective immunity against the disease are still largely unknown. In this study, surface plasmon resonance technology was used to evaluate the affinity (measured as k(d)) of naturally acquired...
G Puntoriero et al.
The EMBO journal, 17(13), 3521-3533 (1998-07-03)
The hypervariable region 1 (HVR1) of the putative envelope protein E2 of hepatitis C virus (HCV) is the most variable antigenic fragment in the whole viral genome and is mainly responsible for the large inter-and intra-individual heterogeneity of the infecting...
Ming Hou et al.
European journal of haematology, 70(6), 353-357 (2003-05-21)
The treatment of chronic idiopathic thrombocytopenic purpura (ITP) is difficult in those unresponsive to corticosteroids and/or splenectomy. We attempted to induce durable response in 21 patients with refractory ITP by applying mycophenolate mofetil (MMF) (1.5-2.0 g/d), a novel immunosuppressive agent....
Cross-reactive phage-displayed mimotopes lead to the discovery of mimicry between HSV-1 and a brain-specific protein.
Cortese I, et al.
Journal of Neuroimmunology, 113(1), 119-128 (2001)
Antibody-based serology tests are useful in identifying subjects with an adaptive immune response to the SARS-CoV-2 virus. Anti-human immunoglobulin antibodies allow for quick and simple, yet reliable assays with easy readouts and can also be adapted for high-throughput screening.
Read More

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.